Praxair Reports Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
Praxair (PX) Tops Q2 EPS by 3c
July 26, 2018 6:16 AM EDTPraxair (NYSE: PX) reported Q2 EPS of $1.72, $0.03 better than the analyst estimate of $1.69. Revenue for the quarter came in at $3.06 billion versus the consensus estimate of $3.05 billion.
For earnings history and earnings-related data on Praxair (PX) click here.
... More